|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 05-05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 04-28 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
Performance
| 1 day | +0.21% | ||
| 6 months | +1.47% | ||
| Current year | +1.76% | ||
| 1 year | +136.76% | ||
| 3 years | +6.78% | ||
| 5 years | +60.11% | ||
| 10 years | +113.09% |
Volumes
marketsDaily volume
5,285,334
Estimated daily volume
5,285,334
Avg. Volume 20 sessions
2,849,117
Daily volume ratio
1.86
Avg. Volume 20 sessions USD
41,283,705.33
Record volume 1
188,236,354
Record volume 2
55,625,760
Record volume 3
38,443,411
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
4,549,870,316
Net sales ()
634,210,000
Number of employees
511
Sales / Employee (USD)
1,241,115
Free-Float
99.31 %
Free-Float capitalization (USD)
4,518,668,593
Average Daily Capital Traded
0.91%
Indicators
Moving average 5 days
14.47
Moving average 20 days
14.46
Moving average 50 days
14.4
Moving average 100 days
13.77
Price spread / (MMA5)
-0.14%
Price spread / (MMA20)
-0.21%
Price spread / (MMA50)
-0.62%
Price spread / (MMA100)
-4.97%
RSI 9 days
76.11
RSI 14 days
72.15
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -.--% | +136.76% | +6.78% | 4.55B | |
| +2.61% | +1.91% | +1.70% | +13.91% | 47.88B | |
| -1.60% | -1.29% | +385.56% | +603.70% | 39.09B | |
| -0.98% | +2.75% | +11.18% | +45.45% | 36.75B | |
| +1.90% | +22.79% | +25.18% | +9.47% | 40.55B | |
| +1.47% | +4.90% | +6.48% | +43.52% | 27.96B | |
| -0.94% | -1.23% | - | - | 16.77B | |
| +2.44% | +10.02% | +29.11% | +129.56% | 15.94B | |
| +0.18% | -1.46% | +4.92% | +10.14% | 13.55B | |
| -1.14% | +6.94% | -6.05% | -29.33% | 13.81B | |
| Average | +0.39% | +1.88% | +66.09% | +92.58% | 25.68B | |
| Weighted average by Cap. | +0.54% | +2.77% | +74.29% | +122.31% |
Historical Quotes: Amicus Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| Current year | 14.2 |  | 14.5 |
| 1 year | 5.92 | | 14.5 |
| 3 years | 5.51 | | 14.57 |
| 5 years | 5.51 | | 14.57 |
| 10 years | 4.41 | | 25.39 |
Monthly variations
Annual variations
| 2026 | +1.76% | ||
| 2025 | +51.17% | ||
| 2024 | -33.62% | ||
| 2023 | +16.22% | ||
| 2022 | +5.71% | ||
| 2021 | -49.98% | ||
| 2020 | +137.06% | ||
| 2019 | +1.67% | ||
| 2018 | -33.43% | ||
| 2017 | +189.54% | ||
| 2016 | -48.76% | ||
| 2015 | +16.59% | ||
| 2014 | +254.04% | ||
| 2013 | -12.31% | ||
| 2012 | -22.09% | ||
| 2011 | -26.81% | ||
| 2010 | +18.39% | ||
| 2009 | -50.25% | ||
| 2008 | -25.77% | ||
| 2007 | -25.50% |
- Stock Market
- Stocks
- FOLD Stock
- Quotes Amicus Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
